| Literature DB >> 36135763 |
Cili Wang1,2, Jiarui Zhang1,2, Xing Shi1,2, Kai Li1,2, Fengling Li3, Xuli Tang4, Guoqiang Li1,2, Pinglin Li1,2.
Abstract
Five new cembranes, named sarcoeleganolides C-G (1-5), along with three known analogs (6-8) were isolated from soft coral Sarcophyton elegans collected from the Yagong Island, South China Sea. Their structures and absolute configurations were determined by extensive spectroscopic analysis, QM-NMR, and TDDFT-ECD calculations. In addition, compound 3 exhibited better anti-inflammation activity compared to the indomethacin as a positive control in zebrafish at 20 μM.Entities:
Keywords: Sarcophyton elegans; anti-inflammation activity; cembranes; sarcoeleganolides C–G
Year: 2022 PMID: 36135763 PMCID: PMC9506240 DOI: 10.3390/md20090574
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Figure 1Structures of compounds 1–8.
1H and 13C NMR data of sarcoeleganolides C–G (1–5).
| No. | 1 a | 2 a | 3 b | 4 a | 5 a | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 160.7, qC | 158.3, qC | 160.0, qC | 151.9, qC | 161.6, qC | |||||
| 2 | 4.94, m | 79.1, CH | 108.3, qC | 4.91, d, (10.0) | 78.4, CH | 148.2, qC | 5.45, d, (10.5) | 79.9, CH | ||
| 3 | 2.77, d, (4.2) | 61.5, CH | 5.16, s | 120.6, CH | 4.74, d, (10.0) | 125.3, CH | 5.23, s | 117.0, CH | 4.89, d, (10.5) | 120.0, CH |
| 4 | 61.5, qC | 143.8, qC | 139.0, qC | 72.0, qC | 144.7, qC | |||||
| 5a | 1.37, m | 38.8, CH2 | 2.20, m | 40.2, CH2 | 2.38, dd, (10.0, 3.0) | 46.2, CH2 | 2.16, m | 48.5, CH2 | 2.32, m | 39.5, CH2 |
| 5b | 2.08, m | 2.20, m | 2.04, t, (11.5) | 2.03, m | 2.20, m | |||||
| 6a | 2.20, m | 23.7, CH2 | 2.35, m | 24.6, CH2 | 5.36, td, (10.0, 2.0) | 71.1, CH | 4.30, t, (9.0) | 73.4, CH | 2.20, m | 24.2, CH2 |
| 6b | 2.08, m | 2.14, m | 2.35, m | |||||||
| 7 | 5.05, t, (7.2) | 124.3, CH | 5.02, t, (6.6) | 125.7, CH | 5.19, d, (10.0) | 127.3, CH | 4.88, d, (9.0) | 124.8, CH | 4.92, d, (5.0) | 123.0, CH |
| 8 | 135.2, qC | 134.3, qC | 141.9, qC | 141.1, qC | 135.5, qC | |||||
| 9a | 2.11, m | 38.8, CH2 | 2.29, m | 37.0, CH2 | 2.61, td, (14.0, 2.5) | 29.1, CH2 | 2.10, m | 38.7, CH2 | 2.03, m | 33.9, CH2 |
| 9b | 2.18, m | 2.03, m | 1.76, m | 2.10, m | 2.03, m | |||||
| 10a | 2.26, m | 24.4, CH2 | 2.06, m | 24.2, CH2 | 1.24, m | 24.3, CH2 | 2.22, m | 24.3, CH2 | 1.71, m | 34.4, CH2 |
| 10b | 2.20, m | 1.34, m | 1.86, m | 2.10, m | 1.71, m | |||||
| 11 | 5.09, t, (6.6) | 126.4, CH | 2.69, dd, (9.6, 3.3) | 61.5, CH | 2.30, dd, (10.5, 2.5) | 58.8, CH | 4.86, d, (4.0) | 125.9, CH | 3.98, t, (6.5) | 72.1, CH |
| 12 | 133.6, qC | 61.6, qC | 59.9, qC | 131.7, qC | 151.9, qC | |||||
| 13a | 2.04, m | 36.6, CH2 | 1.68, m | 34.0, CH2 | 1.09, m | 35.2, CH2 | 2.33, m | 36.2, CH2 | 2.24, m | 32.1, CH2 |
| 13b | 2.45, m | 1.89, m | 1.63, m | 2.33, m | 2.17, m | |||||
| 14a | 2.74, m | 24.9, CH2 | 2.45, m | 23.4, CH2 | 1.74, m | 22.0, CH2 | 2.54, m | 22.5, CH2 | 2.26, m | 27.0, CH2 |
| 14b | 2.39, m | 2.14, m | 1.59, m | 2.54, m | 2.46, m | |||||
| 15 | 124.0, qC | 126.4, qC | 124.0, qC | 123.2, qC | 124.2, qC | |||||
| 16 | 174.4, qC | 172.2, qC | 173.9, qC | 170.0, qC | 174.9, qC | |||||
| 17 | 1.83, s | 8.8, CH3 | 1.90, s | 8.8, CH3 | 1.61, s | 8.8, CH3 | 1.93, s | 9.3, CH3 | 1.87, s | 9.0, CH3 |
| 18 | 1.53, s | 17.9, CH3 | 1.57, s | 15.9, CH3 | 1.34, s | 18.3, CH3 | 1.45, s | 32.9, CH3 | 1.78, s | 15.9, CH3 |
| 19 | 1.58, s | 16.1, CH3 | 1.66, s | 15.0, CH3 | 1.46, s | 22.4, CH3 | 1.66, s | 17.2, CH3 | 1.64, s | 17.1, CH3 |
| 20 | 1.68, s | 17.0, CH3 | 1.29, s | 16.6, CH3 | 1.11, s | 17.3, CH3 | 1.60, s | 17.1, CH3 | 5.19, s; 5.02, s | 110.9, CH2 |
| 21 | 3.14, s | 50.2, CH3 | 169.4, qC | 3.21, s | 55.1, CH3 | |||||
| 22 | 1.65, s | 20.9, CH3 | ||||||||
a Spectra recorded in chloroform -d4. b Spectra recorded in benzene -d6. c Spectra recorded at 600 MHz. d Spectra recorded at 150 MHz. e Spectra recorded at 500 MHz. f Spectra recorded at 125 MHz.
Figure 2Selected 1H–1H COSY and HMBC correlations of compounds 1–5.
Figure 3Key NOESY and 1D-NOE correlations of 1–5.
Figure 4Experimental and calculated ECD spectra of 1–5.
Figure 5(a) Quantitative analysis of macrophages in the region of inflammatory sites in zebrafish treated with sarcoeleganolides C–G (1–5) in zebrafish at 20 μM. (b) Images of inflammatory sites in CuSO4-induced transgenic fluorescent zebrafish (Tg:zlyz-EGFP) expressing enhanced green fluorescent protein (EGFP) treated with sarcoeleganolides C–G (1–5), using indomethacin as a positive control. #### Indicates that the CuSO4 model group shows very significant differences compared to the control group (p < 0.01). ** Indicates that the sample groups show significant differences compared to the CuSO4 model group (p < 0.01).